分泌型磷蛋白1(SPP1)被确定为低级别胶质瘤的预后因素
本研究利用癌症细胞系百科全书、Oncomine和癌症基因组图谱数据库,评估SPP1在低级别胶质瘤中的预后价值。结果显示,低级别胶质瘤中SPP1 mRNA表达升高与患者总生存期较差显著相关,多因素Cox回归分析表明SPP1可能为独立预后因素。
要点
- 低级别胶质瘤中SPP1 mRNA高表达与总生存期较差显著相关。
- 多因素Cox回归显示SPP1可能为低级别胶质瘤的独立预后因素。
- SPP1在胶质母细胞瘤中较正常脑组织显著高表达,但在低级别胶质瘤中未见显著高表达。
核心结论
- SPP1过表达与低级别胶质瘤患者总生存期较差相关。
- SPP1可被视为低级别胶质瘤的独立预后因素。
研究设计与样本
- 利用癌症细胞系百科全书数据库中约1000个癌细胞系的数据探索SPP1 mRNA表达。
- 挖掘Oncomine数据库评估SPP1在低级别胶质瘤、胶质母细胞瘤和正常脑组织中的mRNA表达。
- 分析癌症基因组图谱数据库中SPP1 mRNA表达与胶质瘤患者总生存期的相关性。
主要发现
- 在癌症细胞系百科全书数据库中,胶质瘤的SPP1 mRNA表达在所有癌细胞系中排名第八高。
- Oncomine数据库数据显示,SPP1在胶质母细胞瘤中较正常脑组织显著高表达,但在低级别胶质瘤中较正常脑组织未见显著高表达。
- 癌症基因组图谱RNA-Seq数据显示,低级别胶质瘤中SPP1 mRNA表达升高与患者生存结局较差显著相关。
- 多因素Cox回归分析显示SPP1可能为低级别胶质瘤的独立预后因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Secreted phosphoprotein 1 (SPP1) is an important extracellular glycoprotein that is associated with immune regulation, tumorigenesis, and cell signaling. However, the prognostic value of SPP1 in patients with glioma has not yet been clarified, especially in lower-grade gliomas. The objective of this study is to evaluate the prognostic merit of SPP1 in lower-grade gliomas. METHODS: The messenger RNA (mRNA) expression of SPP1 in about 1000 cancer cell lines was explored by using the data from the Cancer Cell Line Encyclopedia database. The Oncomine database was mined to evaluate the mRNA expression of SPP1 in lower-grade glioma, glioblastoma, and normal brain tissues. The correlation between SPP1 mRNA expression and overall survival of patients with glioma from The Cancer Genome Atlas database was analyzed. RESULTS: SPP1 mRNA expression of glioma was ranked as the eighth highest of all cancer cell lines in the Cancer Cell Line Encyclopedia database. The data from the Oncomine database suggested that SPP1 expression was significantly high in glioblastoma compared with normal brain tissues but was not significantly high in lower-grade glioma compared with normal brain tissue. Analysis of the RNA-Seq data from The Cancer Genome Atlas database showed that the increased SPP1 mRNA expression in lower-grade glioma was significantly associated with poor survival outcomes in patients with lower-grade glioma. Multivariate Cox regression analysis showed that SPP1 might be considered as an independent prognostic factor in lower-grade gliomas. CONCLUSIONS: The present study showed that SPP1 overexpression is related to worse overall survival in patients with lower-grade glioma. Moreover, SPP1 could be considered as an independent factor in lower-grade gliomas.
引用
- Chen J, Hou C, Zheng Z, et al. Identification of Secreted Phosphoprotein 1 (SPP1) as a Prognostic Factor in Lower-Grade Gliomas. World Neurosurg. 2019. PMID: 31295606. doi:10.1016/j.wneu.2019.06.219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。